Karyopharm Therapeutics Inc
(FRA:25K)
€
0.9168
-0.0296 (-3.13%)
Market Cap: 111.00 Mil
Enterprise Value: 136.94 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 73/100 Karyopharm Therapeutics Inc (FRA:25K) Transcripts
- Q1 2024 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 08, 2024€1.06 (+3.41%)Earnings
- Q4 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 29, 2024€1.06 (-15.69%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 02, 2023€0.7496 (-6.25%)Earnings
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Karyopharm Therapeutics Inc at HC Wainwright Investment Conference - New York TranscriptSep 11, 2023
- Q2 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 02, 2023€1.51 (-7.77%)Earnings
- Karyopharm Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Q1 2023 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 04, 2023€2.62 (-18.49%)Earnings
- Karyopharm Therapeutics Inc to Host Investor Webcast on Selinexor Data in Patients with Treatment-Naive Myelofibrosis at AACR 2023 TranscriptApr 18, 2023
- Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 15, 2023€3.38 (+9.09%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Karyopharm Therapeutics Inc Investor and Analyst Event at ASH TranscriptDec 12, 2022
- Q3 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 03, 2022€4.59 (-0.69%)Earnings
- Karyopharm Therapeutics Inc at Robert W Baird Global Healthcare Conference TranscriptSep 13, 2022
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 04, 2022€4.77 (+3.82%)Earnings
- Karyopharm Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Karyopharm Therapeutics Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Q1 2022 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 05, 2022€5.9 (-0.10%)Earnings
- Karyopharm Therapeutics Inc at Canaccord Genuity Horizons in Oncology Conference (Virtual) TranscriptApr 14, 2022
- Karyopharm Therapeutics Inc SIENDO Study Results Call TranscriptMar 17, 2022
- Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Q4 2021 Karyopharm Therapeutics Inc Earnings, 2022 Financial Outlook and SIENDO Topline Results Discussion Call TranscriptFeb 08, 2022
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Karyopharm Therapeutics Inc Virtual Investor Day TranscriptDec 08, 2021
- Karyopharm Therapeutics Inc at Jefferies London Healthcare Conference (Virtual) - On-Demand TranscriptNov 18, 2021
- Q3 2021 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 03, 2021€6.9 (+38.83%)Earnings
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Karyopharm Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) - Pre-Recorded TranscriptSep 13, 2021
- Q2 2021 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 05, 2021€4.98 (-25.77%)Earnings
- Karyopharm Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2021
- Karyopharm Therapeutics Inc Annual Shareholders Meeting TranscriptMay 21, 2021
- Q1 2021 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 03, 2021€7.45 (-5.67%)Earnings
- Karyopharm Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 11, 2021€12.96 (-1.97%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Karyopharm Therapeutics Inc - Karyopharm XPOVIO® FDA Approval in Multiple Myeloma Conference Call TranscriptDec 18, 2020
- Karyopharm Therapeutics Inc - Investor And Analyst ASH Event (Virtual) TranscriptDec 08, 2020
- Karyopharm Therapeutics Inc - Phase 3 SEAL Top-Line Results Conference Call TranscriptNov 20, 2020
- Karyopharm Therapeutics Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- Q3 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 02, 2020€12.39 (-4.84%)Earnings
- Karyopharm Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Q2 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 04, 2020€13.49 (-2.95%)Earnings
- Karyopharm Therapeutics Inc to Discuss The FDA's Approval Of XPOVIO TranscriptJun 22, 2020
- Karyopharm Therapeutics Inc BOSTON Data Conference Call TranscriptMay 29, 2020
- Karyopharm Therapeutics Inc Annual Shareholders Meeting TranscriptMay 21, 2020
- Karyopharm Therapeutics Inc at RBC Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Q1 2020 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 05, 2020€18.9 (+8.00%)Earnings
- Karyopharm Therapeutics Inc - Discuss Selinexor As A Potential Treatment For Hospitalized Patients With COVID-19 TranscriptApr 07, 2020
- Karyopharm Therapeutics Inc. Phase 3 BOSTON Study Top-line Results Conference Call TranscriptMar 02, 2020
- Q4 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 13, 2020€15.1 (-3.82%)Earnings
- Karyopharm Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Q3 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptNov 04, 2019€12.3 (+18.27%)Earnings
- Q2 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptAug 06, 2019€6.87 (-5.63%)Earnings
- Karyopharm Therapeutics Inc Corporate Call TranscriptJul 03, 2019
- Karyopharm Therapeutics Inc at JMP Securities Life Science Conference TranscriptJun 19, 2019
- Q1 2019 Karyopharm Therapeutics Inc Earnings Call TranscriptMay 09, 2019€4.12 (-2.60%)Earnings
- Q4 2018 Karyopharm Therapeutics Inc Earnings Call TranscriptFeb 28, 2019€3.7 (-6.33%)Earnings
- 1